Opinions & Advice

From due diligence and IP valuation to strategic advice and opinions of counsel, Sterne Kessler has the insights you need to proceed with confidence.

Related News & Insights

In the News

June 2, 2020

Amgen Drops Alexion Blood Drug IPRs, Gets 2025 License

Law360

PTAB Strategies and Insights

May 27, 2020

PTAB Strategies and Insights – May 2020

Articles

May 27, 2020

Should USPTO Be Able to Make New Law Without Rulemaking?

Sterne, Kessler, Goldstein & Fox